The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.

Source:http://linkedlifedata.com/resource/pubmed/id/15679714

Download in:

View as

General Info

PMID
15679714